BDBM350095 US10208040, Example 1-12::US11254669, Example 1-12::US11667637, Example 1-12

SMILES CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CN(C)[C@H](C(=O)N3CCN(C(C)C)CC3)C4)n[nH]c2c1

InChI Key InChIKey=FIXODQLYPRSTCO-UHFFFAOYSA-N

Data  12 KI

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 350095   

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
6/19/2022
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/9/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/9/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/21/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
6/19/2022
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.0600nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/21/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/9/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
7/9/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
6/19/2022
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/21/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
6/19/2022
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM350095(US10208040, Example 1-12 | US11254669, Example 1-1...)Copy SMILESCopy InChI

Affinity DataKi:  0.25nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/21/2019
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL